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Abstract 
Background: Historically, goal-directed fluid therapy (GDFT) has been shown to improve 
patient outcomes when used in the perioperative setting for specific cases (colorectal, etc). When 
anesthesia providers use GDFT protocols, intraoperative fluid therapy is” patient specific” via 
the use of dynamic patient-specific physiologic parameters. 
Objectives: The aim of the study is to assess whether GDFT improved patient-specific fluid 
administration. A secondary aim was to assess adherence to the instated GDFT protocol. 
Method: A retrospective chart review was conducted on 201 patients undergoing total hip 
arthroplasty (THA) procedures following implementation of a GDFT protocol at the University 
of Illinois at Chicago Hospital.  
Results: The compliant group consisted of older, heavier, sicker (higher ASA score) patients 
whom had more EBL during surgery. The compliant group showed a moderate-strong positive 
correlation between fluid output and fluid administration (r=0.664), while the group that did not 
utilize the EV-1000™ monitor and GDFT protocol had a weaker linear relationship (r=0.373). 
When the protocol was used, practitioners were compliant in over 50 percent of cases for over 70 
percent of the surgical time. 
Conclusion: Trends suggest improved patient-specific precision of fluid administration when a 
GDFT protocol is used. Further evaluations of a GDFT for THA procedures should be conducted 
for increased protocol validity. 
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Background 
Anesthesia providers administer intravenous fluid replacement during the perioperative 
period. Fluid replacement can include crystalloid, colloid, or blood products for patient 
maintenance, dehydration, and intraoperative fluid loss. Literature suggests that both inadequate 
and excessive fluid administration can have negative impacts on patient outcomes (Peng, Li, 
Cheng, & Ji, 2014, Horosz, Nawrocka, & Malec-Milewska, 2016). Too much fluid can result in 
tissue edema and organ dysfunction, while not enough fluid can result in poor organ perfusion 
and organ injury. Other negative outcomes include: increased length of hospital stay, post-
operative ileus, metabolic derangements, organ dysfunction, and cardiovascular compromise.  
Horosz, Nawrocka, and Malec-Milewska (2016) state that excessive crystalloid administration 
can result in tissue edema, hindering intestinal anastomoses and delaying return of intestinal 
motor functions (possibly leading to prolonged paralytic ileus). By eliminating preoperative 
bowel preparations the patient’s preoperative fluid and electrolyte status is assumed to be 
normal, thus decreasing the need for high-volume intraoperative fluid replacement. 
 Traditionally, fluid management approaches have utilized formulas and fixed-volume 
methods to maintain euvolemia in the intraoperative period.  These methods include weight-
based calculations assessing basal requirements as well as preoperative fluid deficits.  
Intraoperatively, anesthesia providers analyze static and dynamic indicators such as mean arterial 
pressure, heart rate, central venous pressure, urine output, actual/estimated blood loss, and 
arterial blood gases to guide fluid replacement administration (Trinooson & Gold, 2013).  The 
previously described decision-making process for fluid administration has led to wide spread 
differences in intraoperative fluid therapy from provider-to-provider.  Recent goals for 
intraoperative fluid administration are aimed at goal-directed fluid therapy.  The target of goal-
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directed therapy is optimization of cardiac output and end organ tissue oxygen delivery while 
preventing both fluid overload and under resuscitation (Warnakulasuriya, Davies, Wilson, & 
Yates, 2016).   
Newer innovations for measurement of patient fluid status have helped provide quantitative 
indicators for fluid administration. For example, volume status indicators such as stroke volume 
variation and cardiac index or cardiac output used to only be available via invasive monitors 
such as pulmonary artery catheters.  These invasive monitors’ benefits often did not outweigh the 
risk of placement and thus, were not routinely used.  As new technology has become available it 
is possible to monitor such values with non-invasive monitors for routine surgical procedures.  
Non-invasive monitors include esophageal doppler and plethysmographic variability index 
(measured via pulse-oxymetry). 
In 1995, Danish surgeon, Henrik Kehlet published controversial thoughts surrounding 
perioperative care that encompass unbalanced fluid administration. Those thoughts served as a 
stepping stone for the enhanced recovery after surgery (ERAS) protocols that are seen in practice 
today (Horosz, Nawrocka, & Malec-Milewska, 2016).  
 ERAS recommendations include the following: 
Preoperative preparation and counseling, curtailed fasting, avoidance of preoperative 
bowel preparation, preoperative supply of carbohydrate-rich drinks, the avoidance of 
pharmacological premedication, thromboembolism prophylaxis, antibiotic prophylaxis,  
epidural anaesthesia, intraoperative use of short-acting anaesthetics and opioids, 
restricted parenteral supply of sodium and fluids, prevention of hypothermia, prevention 
of postoperative nausea and vomiting (PONV), pain management based on non-opioid 
drugs, early enteral nutrition, stimulation of GI motor activity, limited use of naso-gastric 
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tubes, preferences for laparoscopy (with short transverse incisions), avoidance of post-
operative drains when possible, early mobilization, early removal of urinary catheters, 
and evaluations of the implemented protocol and treatment outcomes (Horosz, Nawrocka, 
& Malec-Milewska, 2016, p. 49-50). 
 ERAS protocols call for physiologically-guided intraoperative fluid replacement due to 
the multitude of complications associated with under- or over-hydration. The current research 
study aims to evaluate the compliance and utility of a GDFT protocol at UIC hospital. Evaluation 
of the GDFT protocol includes compliance with the protocol as well as measuring variability in 
fluid administration. 
Problem Statement 
 The wide variation of fluid administration among providers, as well as the potential for 
detrimental patient outcomes necessitates an inquiry into fluid administration protocols. Recent 
implementation of GDFT protocol for use in a selected patient population e.g. total hip 
arthroplasties at University of Illinois at Chicago hospital will be analyzed for clinical 
compliance and impact on fluid administration. 
Purpose Statement 
The purpose of this study is to examine the implementation of a GDFT protocol in the 
intraoperative period for total hip arthroplasties utilizing retrospective analysis of electronic 
medical records.  
Clinical Questions 
In the 24 months following the implementation of a goal directed therapy protocol,  
1. Does use of a GDFT protocol result in less fluid administration? 
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2. Does use of a GDFT protocol reduce variability in net fluid administration (i.e. 
Improve precision)? 
3. What is the percentage of time that providers are compliant with the GDFT protocol 
when the EV-1000™ monitor is used? 
Conceptual Framework 
 This study is guided by two conceptual frameworks. The first, Quality Assurance Model 
Using Research (QAMUR), is a continuation of the conceptual framework utilized during the 
conception of University of Illinois’ GDFT protocol (Watson, Bulechek, & McCloskey, 1987). 
Following identification of a problem and review of the literature, this model is then used for 
either research utilization or research conduction. Original research was utilized to create a 
GDFT protocol and this follow-up study will conduct new research to examine the effect of 
protocol implementation.  
The second conceptual framework used is the Consolidated Framework for 
Implementation Research (CFIR) (Breimaier, Heckermann, Halfens, & Lohrmann, 2015). The 
CFIR uses five domains (intervention characteristics, outer setting, inner setting, characteristics 
of individuals, and process) to explain why an implementation may or may not succeed 
(Breimaier, Heckermann, Halfens, & Lohrmann, 2015). This second theory is useful for 
exploration of anesthetists’ actions that did not seem to be driven by patient-specific data or 
protocol doctrine.  
Literature Review 
Search Method 
A computerized databases search was conducted for this literature review using the 
various combinations of key terms: “fluid administration”, “goal directed therapy”, “enhanced 
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recovery after surgery”, “intraoperative fluid”, and “orthopedic surgery”. Academic Search 
Complete, PubMed and CINAHL databases search yields were reviewed and the most recent 
research articles were selected for review. Fourteen articles were found to be highly relevant to 
the proposed study and are included in this literature review. 
Current Views on Goal-Directed Fluid Therapy 
Goal-directed fluid therapy (GDFT) is an individualized approach to perioperative fluid 
administration using a variety of monitoring devices and dynamic variables including the 
corrected flow time (FTc) and stroke volume (SV), which are objectively provided by a cardiac 
output monitoring device (Miller, Roche, & Mythen, 2015). In the past decade, multiple studies 
have examined GDFT versus traditional intraoperative fluid administration. Recent published 
studies have also described various dynamic fluid status markers such as stroke volume variation 
(SVV), pulse pressure variation (PVV) and systolic pressure variation (SPV) as reliable 
indicators of “fluid responsive physiology” and therefore triggers for intraoperative fluid 
administration (Gallagher & Vacchiano, 2014; Miller, Roche, & Mythen, 2015).  GDFT uses the 
principle of SV optimization through the use of SVV data. SVV and SV data are objective 
parameters available to anesthesia providers when using a cardiac output monitor; used to tailor 
fluid therapy to individual patients (Miller, Roche, & Mythen, 2015). Response to SVV is based 
on the principle that cardiac output operates under the Frank-Starling law (Miller, Roche & 
Mythen, 2015). Frank-Starling and colleagues demonstrated that an increase in ventricular filling 
results in an increased pressure, and thus and increased force of cardiac output, or stroke volume 
(SV) (Solaro, 2007).  SVV is a dynamic indicator that indirectly gives information about the 
filling pressure of the heart. An increase in SVV is indicative of low filling pressures, thus GDFT 
protocols call for administration of fluid. 
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SVV is considered a “dynamic” indicator of fluid status since data is acquired constantly, 
as opposed to “static” traditional indicators such as heart rate (HR), mean arterial pressure 
(MAP), and central venous pressure (CVP) that are collected only at discrete time points. These 
indicators do not necessarily reflect an individual’s fluid status. HR, MAP, and CVP can be 
increased or decreased due to a variety of reasons such as pain or patient positioning (Miller, 
Roche, & Mythen, 2015). The goal of using SVV to direct fluid administration is to reduce 
confounding factors such as pain or patient positioning. 
Another commonly used indicator guiding intraoperative fluid therapy is urine output 
(UO). As urine output declines, providers often increase the rate and volume of infusing fluids. 
Norberg et al. (2005) conducted an animal study that demonstrated a lack of correlation between 
urine output and fluid administration. In this study, sheep were divided into three groups: 1) 
infusion of crystalloid solution only 2) hemorrhage only, and 3) hemorrhage plus infusion. 
Results demonstrated that in the sheep that were hemorrhaged and received an infusion, there 
was pronounced oliguria regardless of fluid infusion (Norberg et al., 2005). Increased 
administration of fluid in the presence of oliguria resulted in fluid retention and expansion of the 
tissue compartment (Norberg et al., 2005). The results of this study translate into the 
intraoperative environment, as many anesthesia providers continue to bolus fluids based on 
decreased urine output. Norberg et al.’s study highlights the lack of correlation between urine 
output and volume status post fluid administration. Fluid administration based on urine output 
has the potential for over resuscitation. 
GDFT Protocol in Orthopedic Surgeries 
A randomized control group trial by Peng, Li, Cheng, and Ji (2014) compared goal-
directed fluid therapy to a control group of subjects undergoing orthopedic surgery. The GDFT 
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group received fluid based on individualized SVV as opposed to the control group (no GDFT 
protocol) that received fluid administration based on traditional indicators such as HR, MAP, and 
CVP. SVV is a reflection of a patient’s individual cardiac performance. Indicators such as MAP, 
and CVP are numbers that may be ideal for one patient, but at the same value, may provide 
inadequate organ perfusion in another patient. Researchers collected data regarding the variables 
mentioned above, as well as time to passage of flatus post-operatively, and volume of fluid 
administered (Peng et al., 2014).  The results of the study revealed that the GDT group had fewer 
hypotensive episodes, shorter postoperative time to flatus, and received lower volumes of 
intraoperative fluid (1,850ml compared to 2,225ml) (Peng et al., 2014).   
Benes et al. (2015) also compared a GDFT group to a control group (no GDFT protocol) 
in patients who underwent total knee arthroplasty or total hip arthroplasty. The GDFT protocol in 
this study was based off of pulse pressure variation (PPV). PPV is a measure that is then used to 
calculate SVV. Fluid was administered to keep the PPV lower than thirteen percent. Benes et al. 
(2015) found that subjects in the control group received significantly higher amounts of fluid and 
had a higher incidence of postoperative complications such as ileus, respiratory compromise and 
postoperative infection. Subjects in the control group also had a longer length of hospital stay 
compared to the GDFT group.  
GDFT Protocol in High-Risk Surgeries 
Increased intraoperative fluid administration is implicated in several postoperative 
complications, such as delayed wound healing and wound infections. A randomized controlled 
trial by Scheeren, Wiesnack, Gerlach, and Marx (2013) demonstrated that postoperative wound 
infection was significantly lower in a GDFT group versus the control group when undergoing 
high-risk surgeries (defined based on patient specific criteria such as comorbidities and urgency 
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of surgery). This study does include potential confounding factors, such as increased transfusion 
of blood products in the control group. This may induce immunosuppression and predispose the 
subjects to poor wound healing, however the rate of wound infections in the GDFT group 
compared to the control was significant, with zero rate in GDFT group versus seven wound 
infections in the control group (Scheeren, et al., 2013). 
Negative Patient Outcomes Averted by GDFT Protocols 
Miller, Roche, and Mythen (2015) have identified key patient outcomes for GDFT 
protocols, which include reduced length of hospital stay, reduced incidence of postoperative 
complications such as wound infections, and reduced mortality 180 days post-surgery. Horosz, 
Nawrocka, and Malec-Milewska (2016) reiterate the fact that intra-operative over-hydration is 
detrimental to the patient. Patients who received less than 2,000 milliliters (mls) in the 
intraoperative period had a decreased length of hospital stay by an average of three days. The 
authors also cited that treatment of hypotension with vasopressors as opposed to a fluid bolus 
reduced the number of postoperative complications by 22% in the Enhanced Recovery After 
Surgery (ERAS) protocol group (Horosz, Nawrocka, & Malec-Milewska, 2016). This is 
important to note because intraoperative hypotension is often treated with a fluid challenge first, 
administering 100-500mls of crystalloid over a short period of time. If the patient is hypotensive 
due to hypovolemia, the hypotension will resolve with fluid administration. These fluid 
challenges can drastically increase the total amount of intraoperative fluid the patient receives.  
Miller, Roche, and Mythen (2014) state that even a modestly positive postoperative fluid 
balance can be detrimental. A weight gain of 3kg (6.6 lbs) after elective colonic resection has 
been shown to be associated with delayed recovery of gastrointestinal function, increased 
complication rate, and extended length of hospital stay. The authors introduce the term “zero 
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balance therapy” and propose that be the terminology used in this patient population. Miller, 
Roche, & Mythen (2014) also discuss the implementation of goal-directed therapy in ERAS 
patients that resulted in an increase in fluid administration when compared to zero balance 
therapy. This is probably attributed to the lack of preoperative hypovolemia traditionally 
experienced due to bowel preps and long NPO times. Finally, the authors also touched upon the 
fact that traditional markers used to guide fluid therapy intraoperatively (such as heart rate and 
mean arterial blood pressure) are not always reliable indicators of blood volume (Miller, Roche, 
& Mythen, 2014).    
Not all studies reported decreased intraoperative fluid administration due to GDFT 
protocols. Phan, An, D’Souza, Rattray, Johnston, and Cowie (2014) conducted a randomized, 
prospective blind study to compare patient outcomes between GDFT ERAS protocol group 
versus traditional fluid restriction group.  Pahn et al. (2014) study resulted in the GDFT protocol 
group receiving more boluses and an overall higher volume of intraoperative colloid 
administration compared to the fluid restriction group. However, no differences in patient 
outcomes in terms of length of hospital stay and post-surgical complications were seen (Phan et 
al., 2014). 
 Trinooson and Gold (2013) performed a literature review of studies that compared GDFT 
protocols with control groups in high risk surgical procedures where fluid administration was at 
the discretion of the anesthesia provider.  Conclusions from that literature review included an 
overall increase in fluid administration as opposed to decreased fluid administration. However, a 
decrease in the number of postoperative complications (7 studies out of 12), and decreased 
length of hospital time (7 studies out of 12) in the GDFT group were reported (Trinooson & 
Gold, 2013).   
Running Head: GDFT: A TWO-YEAR REVIEW
   
 
14 
 In summary, a few studies found no significant difference between GDFT protocols and 
GDFT protocol groups in key patient outcomes, but the majority of studies that utilized GDFT 
protocols resulted in improved postoperative key patient outcomes, as seen in Table 1. In studies 
that used GDFT protocols, it is important to evaluate the data based on compliance with the 
GDFT protocol as a low compliance rate could skew outcomes against GDFT when, in fact, in 
the compliant group outcome may be better. 
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Table 1. Evidence-Based Table on Goal-directed Fluid Therapy  
Author and Year 
 
Study Objectives Methods 
(Design, 
Sample Size, 
Setting, 
Human 
Subjects 
Issues)  
Study Variables or 
Constructs Measured or 
Variables Controlled for 
by Researchers 
Instrument/s 
Used to 
Measure the 
Construct/s 
Statistics Used 
for Data 
Analysis  
Study Findings 
 
 
Conclusion 
Phan, An, D’Souza, Rattray, Johnston, and Cowie, 2014 Comparison of fluid restriction vs. oesophageal Doppler-guided goal-directed therapy (GDT) in elective major colorectal surgery (ERAS program) 
Prospective blinded study, n=100, multi-centre setting in Fitzroy, Victoria, Australia, study had institutional ethics approval, patients consented to participate 
Fluid volume, type of fluid (fluid restriction protocol versus goal-directed protocol), primary outcome: length of stay (LOS), secondary outcomes: complication rate, change in hemodynamic variables and fluid volumes 
Variables mentioned in previous column were obtained via patient’s chart 
Primary outcomes= power analysis, secondary outcomes: continuous data= t-test, non-parametric data= Mann-Whitney U test, hemodynamic parameters= paired t-test, dichotomous data= chi-square statistics 
-GDT group had higher volume of intraoperative colloid (P=0.012). -Primary outcome of LOS was similar between groups: restrictive median=6 & GDT median=6.5 (P=0.421). -There was no statistical significance between groups in regards to secondary outcome of complications. -There were more MAJOR complications in the restrictive group than GDT group (nine vs. one, P=0.007).  
-GDT group received more boluses and an overall larger volume of fluid in the peri-operative period than the restrictive group. -GDT did not confer any significant clinical advantage within an ERAS pathway. -There was no difference in LOS, or minor or major complications between the two groups. 
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Pavlovic, Diaper, Ellenberger, Frei, Bendjelid, Bonhomme, and Licker, 2016 
Outcomes following emergency surgery between two different goal-directed therapy (GDT) groups .  1. Control group going off of standard fluid status indicators 2. Optimized group using data from PiCCOplus monitor (CI, GEDVL, EVLWL) 
Prospective randomized trial, n=43, conducted in a single academic centre in Helsinki, ethics approval, consent by patient and/or family 
Fluid volume and type administered, administration of inotropes, variables driving fluid administration/inotrope use: control group= PPV and conventional targets (MAP, HR, UO, Hb, lactate) intervention group= CI, GEDVI, EVLWI. Primary outcomes= intraoperative change in arterial blood lactate and short-term organ dysfunction. Secondary outcomes= Hospital and ICU LOS, and composite morbidity index ranking. 
Data points gathered retrospectively from patient chart. 
Mann-Whitney or student t tests were used for continuous data and Fisher’s exact tests for categorical data. 
-There was no difference in intraoperative fluids administered between the two groups. -Dobutamine was used in 9 out of 20 patients in optimized group, while none in the control group received dobutamine. -Blood lactate levels changed little in the two groups (-0.2+/- 1.2mm/l in control group and -1.2 +/- 1.4mm/l in optimized group, p=0.078). -ICU and hospital LOS did not differ significantly between groups. -Mortality= 13% in control group and 25% in optimized group was actually much less than predicted by morbidity index ranking (60+/-20 in control and 62+/- in optimized 
-In high risk emergency patients, GDT utilizing PiCCO-derived parameters led to increased use of intraoperative inotropes that were associated with less favorable outcomes -The trial was interrupted due to interim analysis on efficacy and safety.  
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group). -Optimized group had more major complications (95%) versus the control group (40%), P<0.001. Scheeren, Wiesenack, Gerlach, and Marx, 2013 Randomized trial of high-risk surgical patients assigned to control group or goal-directed therapy (GDT) group. GDT was based on continuously monitored stroke volume variation (SVV) and stroke volume (SV). Control group had no practice changes. 
Prospective randomized multicentre study, n=64, ethical approval from ethics committee of University Hospitals, Rostock, Germany. Patients gave informed consent prior to participation. 
Hemodynamic parameters that were collected: heart rate (HR), mean arterial pressure (MAP), arterial oxygen saturation by pulse oximetry (SpO2), central venous pressure (CVP), stroke volume variation (SVV), and stroke volume (SV). Data from the flotrac system (SVV and SV) were made available to the GDT group but was hidden from the control group. A protocol for fluid therapy based on SVV and SV was then followed in the GDT group. Primary outcomes= number of complications (infectious, cardiac, respiratory, renal, hematologic and abdominal), SOFA score (organ dysfunction) 
Data was gathered via chart review and entered into statistical software. 
Number of complications developed post surgery, maximum SOFA score, comparison  performed either by using t-test or Mann-Whitney test (if data deviated from normal distribution. 
-During surgery, both groups received similar amounts of fluids (P=0.86). -  HR, MAP, CVP, SV and SVV were comparable between groups. -SVV decreased in the GDT group (from 9.1 to 8.0%, P=0.048) but not in the control group (8.9 to 8.8%). -Time that SVV <10% was greater in the GDT group versus the control (P=0.41). -Post-operative wound infections was significantly lower in the GDT group (0 vs. 7, P=0.01).  -The number of post-operative complications 
-Fluid management based on SVV and SV optimization decreases post-operative wound infections. -Larger follow-up studies are needed but findings suggest that goal-directed strategy might decrease post-operative organ dysfunction. -Higher volume of  blood transfusions in the control group and resulting immunosuppression may contribute to decreased wound healing.  
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per patient and maximum SOFA score was all lower in the GDT group, although not statistically significant. -The control group tended to receive more red blood cells than the GDT (685 vs. 319 ml, P=0.063).   Fischer, et al., 2016 Comparison of post-operative colorectal surgical patients using photoplethysmography and perioperative hemodynamic optimization algorithm versus a control group (data from EV1000 monitor unavailable). Outcomes being examined are post-operative complications. 
Randomized, controlled, two-arm trial, n=160, randomized via scratch card that is generated using permutated blocks, IRB approval obtained from University Hospital of Caen in France, consent obtained from participants 
Control group variable= mean arterial pressure (MAP), photoplethysmography group variable= stroke volume (SV) and MAP. Primary outcome=incidence of postoperative complication during 30 days following surgery. Secondary outcomes= total number of postoperative complications, length of hospital says, and postoperative mortality. 
Data collected by blinded third party. Primary outcome comparison performed by Fisher exact or Pearson chi-square test. 
Study is taking place from December 2014 tentatively until December 2016. 
Limitations of study include: population being limited to colorectal surgery patients, study population is of intermediate risk (not high-risk). 
Norberg, et al., 2005 Assessing fluid shifts in three groups of sheep: A. Infusion only B. Hemorrhage only and C. Hemorrhage plus infusion. 
Randomized trial using animal subjects, n=12 (4 per group), approval obtained from the 
Variables include: cardiac output (CO), mean arterial pressure (MAP), transcapillary flow, plasma volume, and urine output. 
Data was gathered in real time during the experiment. 
Comparison of transcapillary flow amongst the three groups was done using the Wilcoxon signed ranks 
- No significant difference in CO was noted between the three groups. -MAP was transiently decreased in 
-Hemorrhage caused an inhibition of renal output. -There was a marked impairment of diuresis after hemorrhage that caused an accumulation of 
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Institutional Animal Care and Use Committee of the University of Texan Medical Branch, Galveston, TX. 
test.  Interventions were assessed at the 0.05 level of significance.  
group B and increased in group A, group C had higher MAP than hemorrhage alone (B). -Cumulative urinary output was 924+/-371 (group A), 255+/- 135ml (group B), and 537 +/- 233ml (group C). 
infused crystalloids outside the vascular space. This supports the theory that difficulty of determining optimal blood volume substitution during surgery and hemorrhage and supports the suggestion that overhydration might be a common feature, especially if urinary output is used as a monitor of hydration. Benes, Zatloukal, Simanova, Chytra, and Kasal, 2014 Evaluation of cost-effectiveness of goal-directed therapy (GDT) implementation. 
Direct comparison between study groups and control groups originally in a randomized study, n=120 (60 per group), approval from ethics committee at Charles University in Czech Republic was received and informed consent from participants was obtained. 
Variables assessed included: postoperative complications (further divided into subcategories), hospitalization costs, patient care costs, clinical examinations/procedure costs, biochemistry, antimicrobials, radiology diagnostics, and other. 
Data was retrospectively collected from patients whom participated in a previous GDT study. 
Mann-Whitney and Kruskal-Wallis tests were used to assess the difference between study groups. 
-The occurrence of any complication, regardless of allocation, increased the costs of postoperative care by 2295+/- 3611 Euros. -The overall costs of care tended to be lower for GDT versus control (p=0.596), although not statistically significant. -GDT intervention reduced the number of complications (34 vs. 78; p=0.007). 
-The mean cost per patient in the GDT group was lower than the control -Overall, the incidence of postoperative complications was lower for the GDT group compared to the control. 
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Benes, et al, 2015.  Assessment of postoperative morbidity when using goal-directed therapy (GDT) versus control group in two patient surgical categories: total knee arthroplasty and total hip arthroplasty. 
Randomized, two-stage study, n=120 (40 per group: control, GDT, and restrictive), IRB approval received from Charles University Hospital in Czech Republic, all patients gave informed consent. 
Primary outcome= number of patients with any postoperative organ or infectious complication. Secondary outcomes= hospital length of stay and all-cause mortality. 
Blinded investigators evaluated patient data. 
For intergroup comparison: one-way ANOVA. For time-dependent variables: repeated measures ANOVA. Categorical variables tested using chi-square test. Tested at significance level of p=0.005. 
-Rate of complications was higher in control group when compared to GDT group (88% vs. 55%, p=0.02). -Length of hospital stay was increased in control group, likely attributed to the higher incidence of complications 
-Control group patients received significantly higher amounts of fluid compared to both protocol groups. -Overall, GDT has decreased level of postoperative complications.  
Trinooson and Gold, 2013 Literature review of RCTs measuring the impact of perioperative goal-directed therapy (GDT) on outcomes among patients undergoing high-risk surgical procedures 
12 randomized controlled human trials were included; results further narrowed by only including patients inside the perioperative arena, all studies represented level 2 evidence. 
Variables included volume (pulse variation, stroke volume, stroke volume variation), flow (cardiac output, cardiac index, SV), oxygen delivery (mixed venous saturation), postoperative complications and morbidity 
Literature review conducted by authors 
Varied among studies Common themes noted throughout studies: -Decrease in hospital stay among GDT group (100%) 
-More research needs to be done, i.e. Large multi-site trials of various GDT protocols are needed to further evaluate the effects of GDT modalities. 
Warnakulasuriya, Davies, Wilson, and Yates, 2016 Examining a difference in fluid administration when using Pleth Variability Index (PVI) compared to esophageal Doppler in low risk patients undergoing major colorectal surgery. 
Randomized controlled trial, n=34, ethics approval granted by NRES Committee-Yorkshire and The Humber-Leeds West, 
Primary outcome= total volume of fluid administered in the intraoperative period. Secondary outcomes= differences in 24 hour fluid balance, biochemical markers of tissue perfusion, morbidity at days 1,3,5, and 7, the presence of complications, 
Data points collected during trial. Statistical significance level= p<0.05. Analysis of data achieved using independent samples t-test, analysis of variance, Mann-Whitney U test and Fisher 
-There was no significant difference in volume of fluid administered using PVI or Doppler. -Biomarkers did not significantly vary among groups 
-In low-risk patients undergoing major colorectal surgery there was no significant difference in fluid administration, postoperative morbidity, or hospital length of stay. 
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conducted at the York Hospital, written informed consent was obtained. 
and length of hospital stay. exact test. -Post-operative complication rate was higher in the Doppler group; however they did not reach statistical significance. -Median hospital length of stay was 7 for both groups (p=0.735); Miller, Roche, and Mythen, 2014 Literature review of components of ERAS protocols and management of perioperative fluids 
Varied Pre-intra- and post-operative fluid management, Fluid challenge, goal-directed therapy, complications 
Info gathered via lit. review Multiple -One study (Noblett, et a.) had a statistically significant reduction in complications and hospital length of stay in the GDT group (P=0.04, and P=0.005 ,respectively)  
-GDT has been shown to decreased hospital LOS and complications after major surgery.  -In the absence of other concerns, perioperative oliguria should be tolerated. -Intraopertive oliguria was not associated with renal failure, fluid overload results in tissue edema which may directly impact an encapsulated organ such as the kidney and participate in the formation of acute kidney injury. Peng, Li, Cheng, and Ji, 2015 Evaluation of the influence of stroke volume variation (SVV)-based goal-directed therapy (GDT) on splanchnic organ functions and postoperative complications in patients undergoing orthopedic surgery. 
Randomized controlled trial, n=80 (40 in intervention, 40 in control group), approval from Institutional Research Ethics Committee, 
Variables: stroke volume variation (SVV), heart rate (HR), mean arterial pressure (MAP), central venous pressure (CVP), urine output (UO), time to passing first flatus. Intraoperative organ perfusion (via arterial and gastric intramucosal pH, and PCO2 of gastric intramucosa. 
Chart Review Normally distributed data analyzed via paired or unpaired t-tests. Nonnormally distributed data tested via Mann-Whitney U test and Wilcoxon rank-
The mean HR in the GDT group was lower than the control (p=0.028), there were fewer hypotensive episodes in GDT group (p=0.021), Volume of intraoperative 
Main findings: SVV based GDT reduced required volume of intraoperative fluids, maintained hemodynamic stability, and improved perioperative gastrointestinal function.  There was no 
Running Head: GDFT: A TWO-YEAR REVIEW   
 
22 
informed consent obtained from subjects. 
Hemodynamic data, hospitalization, postoperative complications, and mortality also recorded. 
sum test. Categorical data analyzed via Fisher’s exact test. P<0.05 considered statistically significant for each test. 
fluid administration was lower in GDT group (p=0.036). Time to first flatus was shorter in GDT group (p=0.042).  
difference in urine output, hospitalization, complications, or mortality. 
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Methods 
Research Design 
 This study utilized a quantitative, retrospective study design. Utilizing a retrospective 
chart review of the specific patient population (hip arthroplasties at University of Illinois at 
Chicago Hospital), key concepts were used as data points.  The data was analyzed for statistical 
significance and correlation between fluid therapy administration versus patient output 
(including urine output and estimated blood loss). Patient indicators and total fluid 
administration volume were also analyzed for variance between patient ASA score or the use of 
EV-1000 ™ monitoring. 
Sample and Setting 
 This review was approved by the Institutional Review Board (IRB) at UIC and an IRB 
Authorization Agreement was made between UIC and DePaul University’s IRB. Subjects of this 
study included patients undergoing total hip arthroplasty (THA) at University of Illinois at 
Chicago (UIC) Hospital. Case information was obtained from UIC’s electronic charting system, 
Cerner SA-Anesthesia.  
 The sample size was 201 patients over a 23-month period, starting from implementation 
of GDFT protocol in January 2016. Inclusion criteria included: male and female patients aged 
28-88 years, ASA status I, II, III, surgery duration greater than 60 minutes (so as to analyze 
intravenous fluid administration in milliliters per kilogram per hour). Exclusion criteria include: 
ASA IV, emergency surgery, surgery duration less than 60 minutes, and vulnerable populations 
(pregnant women, children). 
Definitions of Key Concepts 
 Key concepts of this study include:  
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Fluid administration. The concept of fluid administration is important, both 
conceptually and operationally. Conceptually, one must understand that fluid administration 
entails replacement of vascular volume and effects patient status and outcomes. Operationally, 
this study looks at fluid administration in terms of quantity and quality. Fluid quantity is 
measured in milliliters. Quality of fluid is documented as type of fluid: crystalloid (lactated 
ringers or normal saline) or colloid (albumin).   
Length of surgery. The length of surgery puts fluid administration into context. 
Generally, the longer the surgery, the more blood loss is involved and/or the need for more fluid 
replacement increases. 
Patient indicators. Patient indicators serve as clues as to why a type or quantity of fluid 
was given, but also as an indicator for patient’s response to fluid administration. Indicators 
included in this study were: estimated blood loss (mls), stroke volume variation (SVV), and urine 
output (mls). 
 ASA status: The American Society of Anesthesiologists physical class status places 
patients into classes I-VI. Classification is based on physical health with class I being a young, 
healthy patient and class VI as a brain dead patient. Classes I-III include: healthy, mild, and 
moderate systemic disease, respectively. Only ASA I-III were included in this study to minimize 
physiologic fluid shifts, deficits, and responses to fluid administration and blood loss that may be 
more profound when a patient is unhealthy. 
Human Subjects Protection 
 Subjects of this study are protected in the following ways. Access to study data is limited 
to the primary investigator, Michelle Pavlik, BSN, RN, and committee members, Randal Dull, 
Ph.D, MD, and Karen Kapanke, DNP, CRNA, whom have all completed Collaborative 
Running Head: GDFT: A TWO-YEAR REVIEW
   
 
25 
Institutional Training Initiative (CITI) training. Strict adherence to Health Insurance Portability 
and Accountability Act (HIPAA) is maintained. All patient information was collected and stored 
using a password protected medical record database. The data analyst had access to datasets with 
patient data in order to ensure validity and accuracy. A de-indentified dataset was provided for 
analysis using arbitrary numbers attached to each patient. Finally, this study was approved by 
institutional review boards at both UIC and DePaul University.  
Data Collection 
 Data collection was completed with assistance from UIC Data Analyst Yash Patel. Data 
was pulled from Cerner SA-Anesthesia by using their Business Objects query system. Data was 
separated into the following four datasets: Descriptive, ClinicalEvents, Actions, and 
MonitoredValues (see Appendix A). There was one record in the Descriptive dataset that 
corresponds to each patient case. Clinical events included any drug of fluid administered. The 
Actions dataset captured monitoring instruments (i.e EV-1000™). The monitored values dataset 
contained blood pressure, stroke volume variation, stroke volume index, and other values 
captured by the EV-1000 ™ and monitoring equipment.  
 Cases were grouped into two categories: compliant and non-compliant. The compliant 
group consisted of cases utilizing the EV-1000™ monitor (and thus utilizing the GDFT protocol) 
while the non-compliant group did not. Use of the EV-1000™ device was inferred from the 
appearance of SVV values in the case record.   
 Objective #1: Evaluate IVF administration amongst groups. Did the EV-1000™ group 
receive less fluid when compared to the non-EV-1000™ group? 
 Objective #2: Is there less variability i.e. more precision in net fluid administration when 
the EV-1000™ is used? 
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 Objective #3: What is the percentage of compliance with the GDFT protocol when the 
EV-1000™ was used? 
Data Analysis 
 Intraoperative data was analyzed using the programming language R. Frequencies, 
means, and standard deviations were calculated for descriptive statistics. Means and standard 
deviations were used for analysis of net fluid administration, ASA category, primary vs. re-do 
THA, as well as body weight comparison amongst the EV-1000™ compliant and non-compliant 
groups. A two-tailed t-test was used to analyze estimated blood loss between EV-1000™ and 
non-EV-1000™ groups. A 95% confidence interval was reported with a p value of ≤0.05 
considered statistically significant. 
 Histograms were used to display intraoperative SVV distribution and stacked bar plots 
were used to analyze fluid administration per each patient (n=201). Finally, scatter plots were 
used to display fluid output vs. input for compliant and non-compliant cases.  
Results 
 A total of 225 adult total hip arthroplasty cases were obtained via Cerner Powerchart for 
analysis. Thirteen cases were duplicates and seven had body weights of zero kilograms recorded 
and were thus excluded from the study. Four cases were additionally excluded from the study 
due to incomplete or missing data. The sample size was then split into two categories, compliant 
and non-compliant based on the use or non-use of the EV-1000™ monitor. 
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 The study sample included 102 males and 103 females ranging in age from 28-88 years. 
Ranges of additional sample descriptives are provided in Appendix A, Figure 2. There were a 
total of sixty-three cases that used the EV-1000™ monitor and 138 that did not. 
 Use of the EV-1000™ monitor was demonstrated by evidence of monitor-specific 
parameters (SVV, SVI, etc.) on the electronic anesthesia record. From cases that used the EV-
1000™ monitor, a time weighted mean SVV was calculated using a midpoint Riemann Sum 
(Figure 3a) and a compound logical function was used to calculate percent time compliant 
(Figure 3b). Percent time compliant is defined as the percentage of time that the SVV value fell 
within the identified goal value of less than twelve percent, per GDT Protocol (Figure 8). Percent 
SVV and percent time compliant values are represented as histograms in Figures 3a and 3b. The 
mean percent SVV is left skewed, meaning the mean SVV for majority of compliant cases did 
fall within the goal percentage of less than twelve percent. Figure 3b shows the histogram for 
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percent time compliant which was right skewed. Over fifty percent of cases using the EV-
1000™ monitor were compliant for seventy percent or greater of the total surgical time. 
 Cumulative fluid values were calculated using the formula (Lactated Ringers + Normal 
Saline 0.9% + Albumin), which was then compared to cumulative EBL and urine (EBL + Urine) 
on the same graph (Figures 4a, 4b, & 4c). Cumulative fluid administration varied from 500-
9,500mL as seen in Figure 4a. Figures 4b and 4c show cumulative fluid values for compliant and 
non-compliant groups with the mean being 2,508mL and 2,410 respectively. 
 Net fluid administration was calculated with the formula (Cumulative Fluids – 
Cumulative Output (EBL + Urine) / Patient Weight/Procedure Duration) with the resultant units 
in milliliters per kilogram per minute (ml/kg/min). Net fluid administration did not vary amongst 
groups with the mean = 0.11mL/kg/min (SD= 0.08) in the compliant group and 0.12mL/kg/min 
(SD= 0.09) in the noncompliant group. In addition, net fluid administration values were colored 
by ASA value (Figures 5b and 5c). As Figure 5b shows, patients in the compliant group 
consisted of almost fifty percent ASA classification threes and ASA twos (SD= 0.50), while the 
non-compliant group had significantly more ASA twos (SD= 0.46) (Figure 5c). The mean ASA 
classification for the compliant group was 2.49 and 2.27 in the non-compliant group.  
 Mean values, standard deviations (SD), and p-values were analyzed for both the 
compliant and non-compliant groups at a 95% confidence interval (CI) using a two-tailed t-test, 
in the following categories: EBL, Fluids (cumulative), Net Fluid administration, ASA category, 
Patient Weight and Patient Age (Figure 6). No significant correlations were found, however 
trend is that the compliant group consisted of older, heavier, sicker (higher ASA score) patients 
whom had more EBL during surgery (compliant EBL mean=728.65, non-compliant EBL 
mean=536.34). 
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 Cumulative output was plotted against fluid administration for total THA cases as well as 
compliant and non-compliant groups (Figures 7a, 7b, and 7c). The reference line in these graphs 
represents a predicted 1:1 relationship between fluid loss and replacement, utilizing the formula 
([3 x EBL] + Urine). The calculated correlation coefficient for fluid output versus input for all 
THA cases was moderately positive (r=0.515). Figure 7b shows a moderate-strong positive 
correlation between fluid output and fluid administration in the compliant group (r=0.664), while 
the group that did not utilize the EV-1000™ monitor and GDFT protocol (Figure 7c) had a 
weaker linear relationship (r=0.373). The data points for cases on figures 7a, 7b, and 7c are also 
color coded according to a formula calculating patient weight multiplied by surgical duration (kg 
x min). Data points plotted in blue have a lower weight x duration score and the data points 
progress in color to an orange color as the weight x duration score increases. 
Discussion 
 This single-center study evaluated the implementation and compliance with a goal-
directed fluid therapy protocol for THA procedures during a two-year period. Overall, there was 
low implementation of the GDFT protocol, with 69 percent of THA cases being non-compliant 
with use of the EV-1000™ monitor. Such low overall protocol implementation may be attributed 
to the fact that the facility only owns a couple of EV-1000™ monitors which may have already 
been in use when some THA procedures started. When the monitor was used, providers followed 
the protocol correctly as evidenced by the high percentage of time compliant. 
 The results of this retrospective chart review showed a higher amount of fluid 
administration when the GDFT protocol was used; the opposite of researchers’ hypothesis of less 
overall fluid administration in the GDFT group. However, a higher EBL and higher ASA score 
was noted in the GDFT protocol-compliant group. Follow-up studies should include randomized 
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groups to avoid this issue. It can be hypothesized that anesthesia providers were more likely to 
use the EV-1000™ monitor for older, heavier, sicker patients or when a greater amount of EBL 
was expected.  
 Net fluid administration did not significantly vary amongst groups, with a mean of 
0.11mL/kg/min administered in the EV-1000™ compliant group and 0.12mL/kg/min in the non-
compliant group. While the overall net amount of fluid administration was not decreased when 
the GDFT protocol was used, there was a stronger correlation between fluid loss and 
administration in the GDFT compliant group (r=0.664). The coloring of case’s weight x duration 
was significant. A case with a lower weight x duration score would be predicted to receive less 
fluid based on traditional replacement formulas and the more orange the data point gets the more 
fluid replacement (i.e. more blue data points in quadrant III and more orange data points in 
quadrant I). This predicted pattern is observed in the non- EV-1000™ group where traditional 
IVF replacement calculations are used (Figure 7c) but there is no obvious pattern of distribution 
in the compliant group (Figure 7b). This leads researchers to believe that fluid administration 
precision did in fact improve, meaning the right patient got the right amount of fluid. While this 
trend would be more heavily emphasized with a larger compliant group, these results are 
positive. These results demonstrate the goal of a truly patient-specific GDFT intervention during 
this study when the EV-1000™  monitor was used. 
Limitations 
 Although this two-year review on implementation of a GDFT protocol showed promising 
trends there were limitations. The most significant limitation being the small sample size of cases 
that utilized the EV-1000™ monitor and protocol. As noted above, there may have been 
provider-dependent discretions when deciding to use the monitor and protocol.  
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 Patient factors could not be controlled, specifically in relation to practitioner 
interventions (ie. fluid bolus). Intravenous fluid administration is often guided by patient vital 
signs and controlling those variables could have provided a more accurate assessment of patient-
directed fluid administration precision.  
Recommendations 
 There are two recommendations based on this study’s findings. First, effort should be 
made to increase GDFT protocol use amongst anesthesia providers during THAs at UIC. Trends 
found in this study look promising and a more robust sample size would benefit further 
evaluations. Re-energizing the implementation of this protocol can be achieved by anesthetist 
education/reminders as well as ease of access to the protocol (i.e. placing protocol on each 
anesthesia cart or in rooms where THA procedures are performed). While more costly, it may be 
beneficial to increase the amount of EV-1000™ monitors available for use at the facility. 
Second, further evaluation of this GDFT protocol is needed to draw strong conclusions, 
especially if controlled factors can be increased in subsequent studies. With more promising 
trends in relation to GDFT protocols, one can infer that it may be beneficial to expand the 
protocol to other surgical specialties in the future. 
Conclusion 
 While the volume of fluid administration did not vary significantly between the two 
groups that were compared, there was a stronger correlation between patient-specific output and 
input when a GDFT protocol was used. Small sample size may have contributed to decreased 
study strength but the trends looked promising. Further research needs to be done to evaluate the 
effect of a GDFT protocol, ideally after increased provider utilization of protocol. Follow-up 
studies may look at patient outcomes such as length of hospital stay or complications amongst 
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EV-1000™ and non- EV-1000™  groups. Continued studies may also look at other factors in 
conjunction with GDFT protocol such as use of tranexamic acid to decrease EBL as well as 
vasopressor use in relation to fluid administration. This retrospective chart review revealed 
promising trends and serves to be a good guide for further protocol evaluations.
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Appendix   
 
Figure 1 
 
  
##     Descriptive  ClinicalEvents         Actions MonitoredValues  
##             205         1056939           17722          695921 Columns pulled by Table: 
## $Descriptive 
##  [1] "Case Number"                   "Person Name- Full"             
##  [3] "Financial Number"              "Sex"                           
##  [5] "Patient Weight"                "Actual Anesthesia Type"        
##  [7] "Actual Procedure"              "Actual Surgery Duration"       
##  [9] "Age- Years (Visit)"            "Anesthesia Duration"           
## [11] "ASA Class"                     "Procedure Duration"            
## [13] "Actual Start Date and Time"    "Procedure Start Date and Time" 
## [15] "Procedure End Date and Time"   "Surgical Case Specialty"       
##  
## $ClinicalEvents 
## [1] "Case Number"                    "Person Name- Full"              
## [3] "Financial Number"               "Clinical Event"                 
## [5] "Clinical Event Result"          "Clinical Event Result Units"    
## [7] "Clinical Event End Date & Time" 
##  
## $Actions 
## [1] "Case Number"                  "Person Name- Full"            
## [3] "Financial Number"             "Action Performed Date & Time" 
## [5] "Action Name"                  "Action Detail Description"    
##  
## $MonitoredValues 
## [1] "Case Number"                 "Person Name- Full"           
## [3] "Financial Number"            "Monitor Category Name"       
## [5] "Monitor Unit of Measure"     "Monitor Name"                
## [7] "Monitored Value Date & Time" "Monitor Charted Value"            
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Figure 2 
 
 
SummaryDescriptiveStats[["SummaryTables"]] 
## $Sex 
##  
## FEMALE   MALE  
##    102    103  
##  
## $`Actual Anesthesia Type` 
##  
##    Block Epidural  General   Spinal  
##        2       15      175       13  
##  
## $`Actual Procedure` 
##  
##          Total Hip Arthroplasty Total Hip Arthroplasty Revision  
##                             176                              29  
##  
## $`ASA Class` 
##  
##   1   2   3  
##   1 135  69  
##  
## $`Surgical Case Specialty` 
##  
## Orthopedics SN  
##            205 
SummaryDescriptiveStats[["SummaryRanges"]] %>% lapply(paste, collapse = " to 
") 
## $`Patient Weight` 
## [1] "36.8 to 146.2" 
##  
## $`Actual Surgery Duration` 
## [1] "65 to 850" 
##  
## $`Age- Years (Visit)` 
## [1] "28 to 88" 
##  
## $`Anesthesia Duration` 
## [1] "138 to 1109" 
##  
## $`Procedure Duration` 
## [1] "36 to 850" 
##  
## $`Actual Start Date and Time` 
## [1] "2016-01-05 07:12:00 to 2017-12-26 09:18:00" 
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Figure 3a 
 
 
 
Figure 3b 
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Figure 4a 
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Figure 4b 
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Figure 4c 
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Figure 5a 
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Figure 5b 
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Figure 5c 
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Figure 6 
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Figure 7a 
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Figure 7b 
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Figure 7c 
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Figure 8 
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Figure 9 
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